Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study ; volume:24 ; number:1 ; day:28 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
BMC pulmonary medicine ; 24, Heft 1 (28.10.2024), 1-10, 12.2024
- Urheber
-
Milesi, Jules
Sampol, Emmanuelle
Benyamine, Audrey
Diai, Shani
Coiffard, Benjamin
Nieves, Ana
Granel, Brigitte
Reynaud-Gaubert, Martine
Bermudez, Julien
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-024-03361-7
- URN
-
urn:nbn:de:101:1-2501172138362.624787025857
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:19 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Milesi, Jules
- Sampol, Emmanuelle
- Benyamine, Audrey
- Diai, Shani
- Coiffard, Benjamin
- Nieves, Ana
- Granel, Brigitte
- Reynaud-Gaubert, Martine
- Bermudez, Julien
- SpringerLink (Online service)
Ähnliche Objekte (12)
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease
Circulating cytokine levels in systemic sclerosis related interstitial lung disease and idiopathic pulmonary fibrosis
Usefulness of nailfold videocapillaroscopy for systemic sclerosis
Pathogenesis of interstitial lung disease in systemic sclerosis
Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
Biomarkers in Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Systemic sclerosis-associated interstitial lung disease: How to manage in 2024?
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
Macrophages as determinants and regulators of systemic sclerosis-related interstitial lung disease
Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases
Extracellular vesicles and interstitial lung disease in systemic sclerosis: State of the art!
CD19 + CD21lo/neg cells are increased in systemic sclerosis-associated interstitial lung disease